Skip to main content
. 2017 Jun 19;18:124. doi: 10.1186/s12931-017-0609-7

Fig. 1.

Fig. 1

Panel (a) - Percent free of exacerbation by beta-blocker use in the Macro placebo arm at 0, 30, 60, 90 and 180 days. Panel (b) – Percent free of exacerbation by beta-blocker use in the STATCOPE trial